Production of a recombinant human T‐cell leukemia virus type‐I trans‐activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen
- 19 June 1991
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 48 (4) , 623-630
- https://doi.org/10.1002/ijc.2910480423
Abstract
A 42-kDa recombinant protein, PX141, consisting of the trans-activator protein encoded by human T-cell leukemia virus (HTLV-I) (tax, antigen) and the amino-terminal fusion peptide of 12 amino acid residues of the a-peptide encoded by the plasmid pUC19 was produced. In order to investigate the immunogenicity of the tax, antigen, mice were immunized with the purified PX141 and 4 anti-tax, monoclonal antibodies (MAbs) designated TAXY-I, TAXY-6, TAXY-7 and TAXY-8 were generated, and their reactivity was characterized along with another anti-tax, MAb, Lt-4. Immunoblot assays showed that all the MAbs reacted with the PX141, the native tax, antigen expressed in various HTLV-I-infected cell lines and the gp68 of MT-2 cells expressing the tax, amino acids 94–353. Immunoblot assays using recombinant, truncated tax, antigens, XD59 (expressing amino acids 180–338) and XD128 (expressing amino acids 1–47 and 286–353) showed that: (I) TAXY-I and Lt-4 did not react with either antigen; (2) TAXY-6 and TAXY-8 reacted with only XD128; and (3) TAXY-7 reacted with both. In addition, TAXY-I, but not the other MAbs, reacted with a putative tax antigen of an STLV-I-infected cell line, designated RfM26-I. Competitive binding assays showed that TAXY-6 and TAXY-8 did not compete against each other. Sera from HTLV-I-infected humans interfered with the binding of all of these anti-tax, MAbs. These results indicate that the tax1 antigen and the PX141 express at least 5 distinct epitopes recognized by human and mouse antibodies.Keywords
This publication has 34 references indexed in Scilit:
- Heterogeneity of Antigen Molecules Recognized by Anti‐tax1 Monoclonal Antibody Lt‐4 in Cell Lines Bearing Human T Cell Leukemia Virus Type I and Related RetrovirusesJapanese Journal of Cancer Research, 1990
- High Risk of Mother‐to‐Child Transmission of HTLV‐I in p40tax Antibody‐positive MothersJapanese Journal of Cancer Research, 1989
- Recent Advances in the Molecular Biology of HTLV-1: Trans-Activation of Viral and Cellular GenesAnnual Review of Immunology, 1987
- Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggeringCell, 1987
- HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITYThe Lancet, 1986
- Molecular Cloning of cDNA Encoding gp68 of Adult T-Cell Leukaemia-associated Antigen: Evidence for Expression of the pX IV Region of Human T-Cell Leukaemia VirusJournal of General Virology, 1985
- Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.Proceedings of the National Academy of Sciences, 1982
- Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProceedings of the National Academy of Sciences, 1980
- Terminal deoxynucleotidyl transferase activity in a cell line (Molt-4) derived from the peripheral blood of a patient with acute lymphoblastic leukemiaBiochemical and Biophysical Research Communications, 1973
- A study of malignant tumours in Nigeria by short-term tissue cultureJournal of Clinical Pathology, 1965